Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bruzzi

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
BMJ (Clinical Research Ed.)|May 16, 1998
Tamoxifen for the prevention of breast cancer. Important questions remain unanswered, and existing trials should continueP Bruzzi
Lancet (London, England)|February 19, 1999
Methodological and ethical difficulties in clinical oncology trials. Di Bella Multitreatment Italian Trial Coordinating GroupR Raschetti, P Bruzzi
BMJ (Clinical Research Ed.)|December 16, 2000
Giving medicine a fair trial. Patients' perspective must be acknowledgedP Bruzzi, M Costantini
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 27, 2002
[Bonferroni in biomedical research]G Assennato, P Bruzzi
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 12, 2009
Why are Cochrane hepato-biliary reviews undervalued by physicians as an aid for clinical decision-making?L Pagliaro, P Bruzzi, M Bobbio
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patientsC Viscoli, P Bruzzi, M Glauser
Endoscopy|May 1, 1982
Left-sided colonoscopy in screening programs. What preparation?V Pugliese, P Bruzzi, H Aste
British Journal of Cancer|December 22, 2011
Role of micronucleus test in predicting breast cancer susceptibility: a systematic review and meta-analysisF Cardinale, P Bruzzi, C Bolognesi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2024
Unlocking methodological insights on oncology efficacy endpoints: from statistical to clinical and vice versa. Letter to the editor regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3' by M. P. Goetz et alR De Sanctis, P Bruzzi, A Zambelli
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
QUOROM and the search for an updated 'clinical method' in the era of evidence-based medicineP G Casali, L Licitra, P Bruzzi
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
BMJ (Clinical Research Ed.)|May 16, 1998
Tamoxifen for the prevention of breast cancer. Important questions remain unanswered, and existing trials should continueP Bruzzi
Lancet (London, England)|February 19, 1999
Methodological and ethical difficulties in clinical oncology trials. Di Bella Multitreatment Italian Trial Coordinating GroupR Raschetti, P Bruzzi
BMJ (Clinical Research Ed.)|December 16, 2000
Giving medicine a fair trial. Patients' perspective must be acknowledgedP Bruzzi, M Costantini
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|August 27, 2002
[Bonferroni in biomedical research]G Assennato, P Bruzzi
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 12, 2009
Why are Cochrane hepato-biliary reviews undervalued by physicians as an aid for clinical decision-making?L Pagliaro, P Bruzzi, M Bobbio
European Journal of Cancer (Oxford, England : 1990)|November 1, 1995
An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patientsC Viscoli, P Bruzzi, M Glauser
Endoscopy|May 1, 1982
Left-sided colonoscopy in screening programs. What preparation?V Pugliese, P Bruzzi, H Aste
British Journal of Cancer|December 22, 2011
Role of micronucleus test in predicting breast cancer susceptibility: a systematic review and meta-analysisF Cardinale, P Bruzzi, C Bolognesi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2024
Unlocking methodological insights on oncology efficacy endpoints: from statistical to clinical and vice versa. Letter to the editor regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3' by M. P. Goetz et alR De Sanctis, P Bruzzi, A Zambelli
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
QUOROM and the search for an updated 'clinical method' in the era of evidence-based medicineP G Casali, L Licitra, P Bruzzi
Pageof 17